about
Cell-based therapy technology classifications and translational challengesThe frequency and skewed T-cell receptor beta-chain variable patterns of peripheral CD4(+)CD25(+) regulatory T-cells are associated with hepatitis B e antigen seroconversion of chronic hepatitis B patients during antiviral treatment.The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter I: current practice and remaining unmet medical needs.The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter II: emerging transformational cytotherapies.Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells.BCR-ABL-specific CD4+ T-helper cells promote the priming of antigen-specific cytotoxic T cells via dendritic cells.
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Progress and prospects for engineered T cell therapies
@ast
Progress and prospects for engineered T cell therapies
@en
Progress and prospects for engineered T cell therapies
@nl
type
label
Progress and prospects for engineered T cell therapies
@ast
Progress and prospects for engineered T cell therapies
@en
Progress and prospects for engineered T cell therapies
@nl
prefLabel
Progress and prospects for engineered T cell therapies
@ast
Progress and prospects for engineered T cell therapies
@en
Progress and prospects for engineered T cell therapies
@nl
P2860
P921
P356
P1476
Progress and prospects for engineered T cell therapies
@en
P2093
Adrian J. Thrasher
P2860
P304
P356
10.1111/BJH.12981
P407
P577
2014-09-01T00:00:00Z